• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Significant data on nasal vaccine soon says Bharat Biotech

|
Google Oneindia News

New Delhi, July 30: Bharat Biotech said that the company was expecting significant data on its intranasal COVID-19 vaccine in the next two and half months.

In another two and half months, we are going to have significant data, the company's founder Krishna Ella said.

Significant data on nasal vaccine soon says Bharat Biotech

The nasal vaccine is perceived to be a game changer in the battle against COVID-19. It is also believed to be more effective, since it is expected to generate immune responses at the site of the infection. It is also easy to scale it up and can produce 100 million doses a month, Ella told a FICCI Capital Markets Conference.

What is a nasal COVID-19 vaccine? Is it better than the jab and how does it work What is a nasal COVID-19 vaccine? Is it better than the jab and how does it work

According to World Health Organisation this nasal vaccines whose clinical trials are underway in India could be a game changer for children.

They could also make for useful booster shots against emerging variants of the virus. And if they work for COVID-19, some immunologists hope that they could kick off a new wave of investment in intranasal vaccines for other diseases.

For Daily Alerts
Best Deals and Discounts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X